A globally experienced clinical development and translational medicine leader recognised for expertise in modern clinical study design and evidence generation, leveraging science, emerging technologies, and strategic innovation to accelerate the development of transformative medicines and improve patient outcomes.
Extensive experience within the headquarters of leading global pharmaceutical organisations, with leadership responsibility for multinational development programs spanning Phase I–IIb through Phase III and IV studies. This has resulted in expertise across the international clinical trial environment — including regulatory pathways, operational optimisation, regional implementation strategies, market access considerations, and evolving healthcare system dynamics. Known for combining scientific rigour with strategic vision to drive efficient development pathways and deliver high-impact clinical programs on a local and global scale.
